Green Cross Medical Science Corporation (KOSDAQ:142280)
South Korea
· Delayed Price · Currency is KRW 3,615.00
-85.00 (-2.30%)
At close: Mar 31, 2025, 3:30 PM KST
KOSDAQ:142280 Revenue
In the year 2024, Green Cross Medical Science had annual revenue of 103.85B KRW with 10.47% growth. Green Cross Medical Science had revenue of 27.75B in the quarter ending December 31, 2024, with 17.51% growth.
Revenue
103.85B
Revenue Growth
+10.47%
P/S Ratio
0.78
Revenue / Employee
811.35M
Employees
128
Market Cap
82.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103.85B | 9.84B | 10.47% |
| Dec 31, 2023 | 94.01B | -19.10B | -16.88% |
| Dec 31, 2022 | 113.11B | 11.43B | 11.25% |
| Dec 31, 2021 | 101.67B | -11.70B | -10.32% |
| Dec 31, 2020 | 113.38B | 31.88B | 39.13% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Kia Corporation | 107.45T |
| Celltrion | 3,557.30B |
| KB Financial Group | 15.01T |